Mesothelioma of the tunica vaginalis: A series of eight cases with uncertain malignant potential

Modern Pathology

Volumn 23, Issue 8, 2010, Pages 1165-1172

  Brimo, Fadi ^a   Illei, Peter B ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

GLUT 1; mesothelioma; paratesticular; tunica vaginalis

Indexed keywords

GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION; TUNICA VAGINALIS;

EID: 77955174002     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.113     Document Type: Article

References (34)

1. Churg A, Cagle PT, Roggli VL. Well differentiated papillary mesothelioma. In: Silverberg SG, Sobin LH (eds). AFIP Atlas of Tumor Pathology: Tumors of the Serosal Membranes, Fourth Series, Fascicle 3 ARP PRESS: Silver Spring, Maryland, 2006, pp 107-109.
2. Davis CJ, Woodward PJ, Dehner LP, Jones MA, Srigley JR, Sesterhenn IA, Gerald WL, Miettinen M, Fetsch JF. Benign mesothelioma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). World Health Organization Classification of Tumours. Pathology and Genetics of the Urinary System and Male Genital Organs. IARCPress: Lyon, 2004, pp 269.
3. Daya D, McCaughey WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer 1990;65:292-296.
4. Gupta NP, Agrawal AK, Sood S, Hemal AK, Nair M. Malignant mesothelioma of the tunica vaginalis testis: a report of two cases and review of literature. J Surg Oncol 1999;70:251-254.
5. Plas E, Riedl CR, Pfluger H. Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters. Cancer 1998;83:2437-2446.
6. Tolhurst SR, Lotan T, Rapp DE, Lyon MB, Orvieto MA, Gerber GS, Sokoloff MH. Well-differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis with contralateral atypical mesothelial hyperpla-sia. Urol Oncol 2006;24:36-39.
7. Attanoos RL, Gibbs AR. Primary malignant gonadal mesotheliomas and asbestos. Histopathology 2000;37: 150-159.
8. Butnor KJ, Sporn TA, Hammar SP, Roggli VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol 2001;25:1304-1309.
9. Cabay RJ, Siddiqui NH, Alam S. Paratesticular papillary mesothelioma: a case with borderline features. Arch Pathol Lab Med 2006;130:90-92.
10. Galateau-Salle F, Vignaud JM, Burke L, Gibbs A, Brambilla E, Attanoos R, Goldberg M, Launoy G. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol 2004;28:534-540.
11. Goldblum J, Hart WR. Localized and diffuse mesothe-liomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multi-cystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 1995;19:1124-1137.
12. Xiao SY, Rizzo P, Carbone M. Benign papillary mesothelioma of the tunica vaginalis testis. Arch Pathol Lab Med 2000;124:143-147.
13. Baker PM, Clement PB, Young RH. Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol 2005;123:724-737.
14. Kerrigan SA, Turnnir RT, Clement PB, Young RH, Churg A. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Cancer 2002;94:378-385.
15. Barbera V, Rubino M. Papillary mesothelioma of the tunica vaginalis. Cancer 1957;10:183-189.
16. Chetty R. Well differentiated (benign) papillary me-sothelioma of the tunica vaginalis. J Clin Pathol 1992;45:1029-1030.
17. Fujii Y, Masuda M, Hirokawa M, Matsushita K, Asakura S. A case of benign mesothelioma of the tunica vaginalis testis. Hinyokika Kiyo 1993;39:89-92.
18. Fukunaga M. Well-differentiated papillary mesothelio-ma of the tunica vaginalis: a case report with aspirate cytologic, immunohistochemical, and ultrastructural studies. Pathol Res Pract 2009;206:105-109.
19. Grove A, Jensen ML, Donna A. Mesotheliomas of the tunica vaginalis testis and hernial sacs. Virchows Arch A Pathol Anat Histopathol 1989;415:283-292.
20. Jones MA, Young RH, Scully RE. Malignant mesothe-lioma of the tunica vaginalis. A clinicopathologic analysis of 11 cases with review of the literature. Am J Surg Pathol 1995;19:815-825.
21. Mikuz G, Hopfel-Kreiner I. Papillary mesothelioma of the tunica vaginalis propria testis. Case report and ultrastructural study. Virchows Arch A Pathol Anat Histol 1982;396:231-238.
22. Attanoos RL, Griffin A, Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and bcl-2. Histopathology, 2003; 43 231-238
23. Cury PM, Butcher DN, Corrin B, Nicholson AG. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperpla-sia and reactive pleural fibrosis. J Pathol 1999;189: 251-257.
24. King J, Thatcher N, Pickering C, Hasleton P. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports. Histopathology 2006;49:561-568.
25. Mayall FG, Goddard H, Gibbs AR. P53 immunostain-ing in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J Pathol 1992;168:377-381.
26. Ramael M, Lemmens G, Eerdekens C, Buysse C, Deblier I, Jacobs W, van Marck E. Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium. J Pathol 1992;168:371-375.
27. Schonherr A, Bayer M, Bocking A. Diagnostic and prognostic value of Ki67 proliferation fraction in serous effusions. Cell Oncol 2004;26:57-62.
28. Sington JD, Morris LS, Nicholson AG, Coleman N. Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelio-ma. Histopathology 2003;42:498-502.
29. Taheri ZM, Mehrafza M, Mohammadi F, Khoddami M, Bahadori M, Masjedi MR. The diagnostic value of ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations. Arch Pathol Lab Med 2008;132:694-697.
30. Kato Y, Tsuta K, Seki K, Maeshima AM, Watanabe S, Suzuki K, Asamura H, Tsuchiya R, Matsuno Y. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol 2007;20:215-220.
31. Shen J, Pinkus GS, Deshpande V, Cibas ES. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol 2009;131:516-523.
32. Chen JL, Hsu YH. Malignant mesothelioma of the tunica vaginalis testis: a case report and literature review. Kaohsiung J Med Sci 2009;25:77-81.
33. Churg A, Cagle PT, Roggli VL. Diffuse malignant tumors of the serosal membranes. In: Silverberg SG, Sobin LH (eds). AFIP Atlas of Tumor Pathology: Tumors of the Serosal Membranes, Fourth Series, Fascicle 3 ARP PRESS: Silver Spring, Maryland, 2006, pp 33-72.
34. Spiess PE, Tuziak T, Kassouf W, Grossman HB, Czerniak B. Malignant mesothelioma of the tunica vaginalis. Urology 2005;66:397-401.